Disclosure Declaration
It is the policy of NLA and AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA and AKH prior to accreditation of the activity. NLA and AKH planners and reviewers have no relevant financial relationships to disclose.
Faculty Disclosures
 |
Future Issues, Public Policy, and Public Awareness of Familial Hypercholesterolemia
Anne C. Goldberg, MD, FACP, FAHA, FNLA
| Advisory Board
|
Genentech; Genzyme/Isis Pharmaceuticals; Merck & Co., Inc.; Roche Pharmaceuticals
|
| Consultant
|
Genentech; Genzyme/Isis Pharmaceuticals; Merck & Co., Inc.; Roche Pharmaceuticals
|
| Contracted Research
|
Abbott Laboratories, Inc.; Amarin;
Amylin Pharmaceuticals; GlaxoSmithKline;
MannKind Corporation; Merck & Co., Inc.;
Novartis Pharmaceuticals;
Regeneron Pharmaceuticals, Inc.; Tolerx, Inc.
|
|
 |
Treatment of Adults with Familial Hypercholesterolemia
Jennifer G. Robinson, MD, MPH, FNLA
| Contracted Research
|
Abbott Laboratories, Inc.; Bristol-Myers Squibb; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd; GlaxoSmithKline; Merck & Co., Inc.; Merck/Schering-Plough Pharmaceuticals, Inc.; Spirocor Ltd.
|
|
 |
Familial Hypercholesterolemia: Prevalence, Genetics, Diagnosis, and Screening
Peter P. Toth, MD, PhD
| Consultant
|
Abbott Laboratories, Inc.; Amgen; Amylin Pharmaceuticals; AstraZeneca; Kowa Pharmaceuticals America, Inc.; Merck & Co., Inc.
|
| Speakers Bureau
|
Abbott Laboratories, Inc.; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck & Co., Inc; Pfizer Inc.; Takeda Pharmaceuticals North America, Inc.
|
|
 |
Familial Hypercholesterolemia: Pediatric Aspects
Samuel S. Gidding, MD
| Advisory Board
|
Merck & Co., Inc.
|
|
 |
Familial Hypercholesterolemia: Management Issues in Adults
Matthew K. Ito, PharmD, FNLA
| Consultant
|
Daiichi Sankyo, Inc.
|
| Speakers Bureau
|
Abbott Laboratories, Inc.; GlaxoSmithKline; Kowa Pharmaceuticals America, Inc.; Merck & Co., Inc.
|
|
Staff and Reviewers Disclosures
AKH Inc., Advancing Knowledge in Healthcare staff, planners and reviewers have no financial relationships to disclose.
National Lipid Association staff, planners and reviewers have no financial relationships to disclose.
